Provider Awareness and Knowledge of Alpha-Gal Syndrome Limited
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, July 27, 2023 -- Awareness and knowledge of alpha-gal syndrome (AGS), an emerging, tick bite-associated immunoglobulin E (IgE)-mediated allergic condition, is limited among health care providers (HCP), and understanding the geographic distribution will help target high-risk populations, according to research published in the July 28 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Ann Carpenter, D.V.M., from the CDC in Atlanta, and colleagues conducted a web-based survey of 1,500 HCPs to examine their knowledge of AGS. The authors found that 42 percent of the HCPs surveyed had never heard of AGS, and fewer than one-third of those who had heard of AGS knew how to diagnose the condition. Two-thirds of respondents indicated that guidelines for AGS diagnosis and management would be useful.
Julie M. Thompson, D.V.M., Ph.D., also from the CDC, and colleagues assessed geographic distribution and magnitude of AGS by examining alpha-gal-specific IgE (sIgE) antibody testing results submitted to the commercial laboratory responsible for almost all testing in the United States before 2022. A total of 357,119 tests were submitted during Jan. 1, 2017, to Dec. 31, 2022, corresponding to 295,400 persons. The researchers found that 30.5 percent of people received a positive test result, and the number with a positive test result increased from 13,371 to 18,885 from 2017 to 2021. Suspected cases predominantly occurred in counties within the Southern, Midwestern, and Mid-Atlantic U.S. Census Bureau regions.
"The results of the current study can aid in initiating national surveillance efforts for this emerging allergic condition and for geographically targeting high-risk populations for public health outreach and HCP education," Thompson and colleagues write.
One author from both studies disclosed ties to the pharmaceutical and medical technology industries.
Abstract/Full Text - Carpenter
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Sharp Increase Seen in Lyme Disease Cases in 2022 After Revised Definition
THURSDAY, Feb. 15, 2024 -- In 2022, there was an increase in the number of reported Lyme disease cases following implementation of a revised surveillance case definition...
Blacks More Likely to Have Disseminated Manifestations of Lyme Disease
THURSDAY, Dec. 14, 2023 -- Black patients are more likely to be diagnosed with disseminated manifestations of Lyme disease (LD) and experience longer time to appropriate...
CDC: Three People Have Died From Rocky Mountain Spotted Fever in New Outbreak
MONDAY, Dec. 11, 2023 -- The U.S. Centers for Disease Control and Prevention is warning of an outbreak of an often-fatal tickborne disease among people who have recently been to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.